Physician profile
David Lopez
NPI 1689877243
$1,744.69
in general payments reported to CMS, 2019-2025
13 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $233 · 2021: $275 · 2022: $375 · 2023: $122 · 2024: $181 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $457.02 | 2021-2024 | |
| Boston Scientific Corporation | $324.73 | 2021-2025 | Watchman Flx, Watchman Access System |
| Siemens Medical Solutions USA, INC. | $156.47 | 2019 | |
| Edwards Lifesciences Corporation | $149.30 | 2020 | |
| Abbott Laboratories | $126.47 | 2024 | Mitraclip |
| Cardiva Medical, INC. | $124.80 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $120.76 | 2022-2024 | Camzyos, Eliquis |
| Abiomed | $84.18 | 2020 | |
| Medtronic, INC. | $80.78 | 2022 | |
| Biotronik Nro, INC. | $54.48 | 2025 | Prospera |
| Novo Nordisk INC | $25.00 | 2025 | Ozempic |
| Heartflow, INC. | $24.97 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.73 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.